Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Return on Assets: 2017-2021

Historic Return on Assets for ENDRA Life Sciences (NDRA) over the last 5 years, with Sep 2021 value amounting to -0.64%.

  • ENDRA Life Sciences' Return on Assets rose 284.00% to -0.64% in Q3 2021 from the same period last year, while for Sep 2021 it was -0.64%, marking a year-over-year increase of 284.00%. This contributed to the annual value of -1.47% for FY2020, which is 38.00% up from last year.
  • As of Q3 2021, ENDRA Life Sciences' Return on Assets stood at -0.64%, which was down 4.94% from -0.61% recorded in Q2 2021.
  • In the past 5 years, ENDRA Life Sciences' Return on Assets registered a high of -0.49% during Q3 2017, and its lowest value of -6.06% during Q1 2017.
  • Moreover, its 3-year median value for Return on Assets was -2.40% (2020), whereas its average is -2.13%.
  • Within the past 5 years, the most significant YoY rise in ENDRA Life Sciences' Return on Assets was 454bps (2018), while the steepest drop was 400bps (2018).
  • Quarterly analysis of 5 years shows ENDRA Life Sciences' Return on Assets stood at -0.79% in 2017, then crashed by 151bps to -2.30% in 2018, then decreased by 16bps to -2.47% in 2019, then skyrocketed by 81bps to -1.66% in 2020, then spiked by 284bps to -0.64% in 2021.
  • Its last three reported values are -0.64% in Q3 2021, -0.61% for Q2 2021, and -0.77% during Q1 2021.